Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 11Nplate

02 8Romiplate

PharmaCompass

01

Brand Name : Nplate

Romiplostim

arrow
iPHEX India
Not Confirmed

Brand Name : Nplate

arrow
iPHEX India
Not Confirmed

Romiplostim

Main Therapeutic Indication : Immunology

Currency : USD

2020 Revenue in Millions : 850

2019 Revenue in Millions : 795

Growth (%) : 7

blank

02

Brand Name : Nplate

Romiplostim

arrow
iPHEX India
Not Confirmed

Brand Name : Nplate

arrow
iPHEX India
Not Confirmed

Romiplostim

Main Therapeutic Indication : Immunology

Currency : USD

2021 Revenue in Millions : 1,027

2020 Revenue in Millions : 850

Growth (%) : 21

blank

03

Brand Name : Romiplate

Romiplostim

arrow
iPHEX India
Not Confirmed

Brand Name : Romiplate

arrow
iPHEX India
Not Confirmed

Romiplostim

Main Therapeutic Indication : Hematology

Currency : USD

2020 Revenue in Millions : 72

2019 Revenue in Millions : 46

Growth (%) : 55

blank

04

Brand Name : Romiplate

Romiplostim

arrow
iPHEX India
Not Confirmed

Brand Name : Romiplate

arrow
iPHEX India
Not Confirmed

Romiplostim

Main Therapeutic Indication : Hematology

Currency : USD

2021 Revenue in Millions : 62

2020 Revenue in Millions : 72

Growth (%) : -4

blank

05

Brand Name : Romiplate

Romiplostim

arrow
iPHEX India
Not Confirmed

Brand Name : Romiplate

arrow
iPHEX India
Not Confirmed

Romiplostim

Main Therapeutic Indication : Hematology

Currency : USD

2022 Revenue in Millions : 79

2021 Revenue in Millions : 62

Growth (%) : 28

blank

06

Brand Name : Nplate

Romiplostim

arrow
iPHEX India
Not Confirmed

Brand Name : Nplate

arrow
iPHEX India
Not Confirmed

Romiplostim

Main Therapeutic Indication : Immunology

Currency : USD

2022 Revenue in Millions : 1,307

2021 Revenue in Millions : 1,027

Growth (%) : 27

blank

07

Brand Name : Romiplate

Romiplostim

arrow
iPHEX India
Not Confirmed

Brand Name : Romiplate

arrow
iPHEX India
Not Confirmed

Romiplostim

Main Therapeutic Indication : Hematology

Currency : USD

2023 Revenue in Millions : 81

2022 Revenue in Millions : 79

Growth (%) : 15

blank

08

Brand Name : Nplate

Romiplostim

arrow
iPHEX India
Not Confirmed

Brand Name : Nplate

arrow
iPHEX India
Not Confirmed

Romiplostim

Main Therapeutic Indication : Immunology

Currency : USD

2023 Revenue in Millions : 1,477

2022 Revenue in Millions : 1,307

Growth (%) : 13

blank

09

Brand Name : Romiplate

Romiplostim

arrow
iPHEX India
Not Confirmed

Brand Name : Romiplate

arrow
iPHEX India
Not Confirmed

Romiplostim

Main Therapeutic Indication : Hematology

Currency : USD

2024 Revenue in Millions : 91

2023 Revenue in Millions : 81

Growth (%) : 12

blank

10

Brand Name : Nplate

Romiplostim

arrow
iPHEX India
Not Confirmed

Brand Name : Nplate

arrow
iPHEX India
Not Confirmed

Romiplostim

Main Therapeutic Indication : Immunology

Currency : USD

2024 Revenue in Millions : 1,456

2023 Revenue in Millions : 1,477

Growth (%) : -1

blank